Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-18 Sale | 2024-10-22 4:17 pm | Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER | 816 | $30 | $24,482 | 266,268 (Direct) | View |
| 2024-04-11 Sale | 2024-04-15 7:02 pm | Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER | 20,000 | $25.07 | $501,478 | 267,084 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-18 Exercise | 2024-10-22 4:17 pm | N/A 2031-06-17 | Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER | 816 | $0 | 266,268 (Direct) | View |
| 2024-10-18 Exercise | 2024-10-22 4:17 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER | 816 | $2.48 | 266,268 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:30 pm | N/A 2034-06-04 | Kura Oncology Inc. | KURA | Collins Helen Louise Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-07 4:12 pm | N/A 2034-06-06 | IO Biotech Inc. | IOBT | Collins Helen Louise Director | 45,642 | $0 | 45,642 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 7:02 pm | N/A 2031-06-17 | Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER | 20,000 | $0 | 267,084 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 7:02 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER | 20,000 | $2.48 | 267,084 (Direct) | View |
| 2024-02-13 Option Award | 2024-02-15 8:46 pm | N/A 2034-02-12 | Enliven Therapeutics Inc. | ELVN | Collins Helen Louise CHIEF MEDICAL OFFICER | 185,000 | $0 | 185,000 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-17 4:47 pm | N/A 2033-11-15 | IO Biotech Inc. | IOBT | Collins Helen Louise Director | 64,238 | $0 | 64,238 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-02 4:45 pm | N/A 2033-05-30 | Kura Oncology Inc. | KURA | Collins Helen Louise Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2023-04-04 Option Award | 2023-04-06 8:32 pm | N/A 2033-04-04 | Enliven Therapeutics Inc. | ELVN | Collins Helen Louise Chief Medical Officer | 206,000 | $0 | 206,000 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 9:32 pm | N/A 2031-06-17 | Enliven Therapeutics Inc. | ELVN | Collins Helen Louise Chief Medical Officer | 287,084 | $0 | 287,084 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-23 4:54 pm | N/A 2032-06-20 | Kura Oncology Inc. | KURA | Collins Helen Louise Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2021-07-28 Option Award | 2021-07-29 5:17 pm | N/A 2031-07-27 | Kura Oncology Inc. | KURA | Collins Helen Louise Director | 65,166 | $0 | 65,166 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 135,547 | $38 | 0 (Direct) | View |
| 2021-03-31 Gift | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 8,085 | $0 | 0 (Direct) | View |
| 2021-04-16 Disposition | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 368,000 | $0 | 0 (Direct) | View |
| 2021-04-16 Option Award | 2021-04-19 7:53 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 66,000 | $0 | 0 (Direct) | View |
| 2021-02-26 Tax Withholding | 2021-03-02 12:08 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 1,158 | $22.23 | 77,632 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-02-26 2:36 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 1,653 | $23.08 | 78,790 (Direct) | View |
| 2021-02-24 Tax Withholding | 2021-02-26 2:36 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 5,091 | $25.71 | 78,790 (Direct) | View |
| 2020-12-11 Exercise | 2020-12-15 12:00 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 22,000 | $0 | 85,534 (Direct) | View |
| 2020-12-11 Tax Withholding | 2020-12-15 12:00 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 11,583 | $16.14 | 85,534 (Direct) | View |
| 2020-11-11 Tax Withholding | 2020-11-13 12:25 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 11,039 | $18 | 97,117 (Direct) | View |
| 2020-11-11 Exercise | 2020-11-13 12:25 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 22,000 | $0 | 97,117 (Direct) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 1:46 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 827 | $4.69 | 64,156 (Direct) | View |
| 2020-03-20 Tax Withholding | 2020-03-23 12:11 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 827 | $2.3 | 64,983 (Direct) | View |
| 2020-02-26 Tax Withholding | 2020-02-26 8:22 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 1,281 | $4.83 | 245,810 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-26 8:22 pm | N/A 2030-02-23 | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 195,000 | $0 | 245,810 (Direct) | View |
| 2020-02-25 Tax Withholding | 2020-02-26 8:22 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 1,862 | $4.87 | 245,810 (Direct) | View |
| 2020-02-05 Tax Withholding | 2020-02-06 6:51 pm | N/A N/A | FIVE PRIME THERAPEUTICS INC. | FPRX | Collins Helen Louise EVP and Chief Medical Officer | 5,345 | $5.13 | 38,953 (Direct) | View |